Paul J Goode

US Patent:

8423130, Apr 16, 2013

Filed:

Oct 23, 2008

Appl. No.:

12/256819

Inventors:

James Thrower - Oakland NJ, US
Paul Goode - Cherry Hill NJ, US
Shai Policker - Tenafly NJ, US
Anat Kliger - Tel-Aviv, IL

Assignee:

Metacure Limited - Hamilton

International Classification:

A61B 5/05

US Classification:

600547

Abstract:

A method is provided that includes providing a fundic impedance signal of a subject sensed during an initial calibration period using at least one implantable fundic sensor of an eating detection device. An indication is received of actual ingestion events of the subject during the initial calibration period. Using a cost function, an analysis is performed of the fundic impedance signal and the actual ingestion events. Responsively to the analysis, a threshold is set, the crossing of which by the fundic impedance signal is indicative of ingestion. The threshold is stored in a memory of the eating detection device. Other embodiments are also described.

US Patent:

20190366084, Dec 5, 2019

Filed:

Mar 8, 2019

Appl. No.:

16/297222

Inventors:

- Dallas TX, US
Edy Sofer - Los Angeles CA, US
Paul V. Goode - Round Rock TX, US
Bevil Hogg - Murrieta CA, US
Shai Policker - Tenafly NJ, US
Matthew Joseph Gani - Seattle WA, US
Jay Miazga - Seattle WA, US
Kaila Raby - Albuquerque NM, US

International Classification:

A61N 1/36
A61B 5/00
A61N 1/05

Abstract:

The present specification discloses devices and methodologies for the treatment of GERD. Individuals with GERD may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow, have improved energy storage requirements, enable improved LES function while concurrently delivering additional health benefits, and enable improved LES function post stimulation termination.

US Patent:

20190054291, Feb 21, 2019

Filed:

Feb 7, 2018

Appl. No.:

15/891209

Inventors:

- Dallas TX, US
Shai Policker - Tenafly NJ, US
Paul V. Goode - Round Rock TX, US
Ofer Glasberg - Zichron Ya'akov, IL

International Classification:

A61N 1/05
A61B 17/04
A61B 17/00
A61B 1/313

Abstract:

A method of laparoscopically implanting an electrically stimulating lead proximate the lower esophageal sphincter (LES) of a patient includes delivering the lead through a port of a laparoscope inserted into the abdominal cavity of the patient through an incision in the abdominal wall. The stimulating electrode is implanted in or proximate the muscularis layer of the lower esophageal wall to treat esophageal reflux disease (GERD). The lead includes a needle and suture at its distal end for pulling the electrode into the muscular wall of the LES. Clips are applied to the suture attached to the distal end of the lead to prevent retrograde movement of the electrode. The lead also includes an anchoring member for anchoring the portion of the lead proximal to the electrode. The method and lead used with the method allow the surgeon to work within the confined anatomy present at the gastroesophageal junction and prevents backwards movement and dislodgment of the electrode. The implantation procedure can be combined with a hiatal hernia repair to repair the hernia and prevent recurrence of a hiatal hernia.

US Patent:

20180296838, Oct 18, 2018

Filed:

Oct 26, 2017

Appl. No.:

15/794209

Inventors:

- Dallas TX, US
Shai Policker - Tenafly NJ, US
Virender K. Sharma - Paradise Valley AZ, US
Paul V. Goode - Round Rock TX, US
Bevil Hogg - Murrieta CA, US

International Classification:

A61N 1/36
A61B 5/00

Abstract:

Methods for electrically stimulating body tissues to improve function or reduce symptoms provide an electrical stimulation system having two or more electrodes that are capable of being switched independently from a hyperpolarizing (depolarizing) state to a hypopolarizing state. Multiple combinations of hyperpolarizing electrodes and hypopolarizing electrodes are created by polarity switching to determine a polarity configuration having the best performance as determined by symptom reporting and clinical diagnostic tests. Polarity switching is triggered manually or is programmed to be switched automatically. Determining the configuration providing electrical stimulation resulting in the greatest benefit allows the system to be operated with one or more electrodes in a hypopolarizing state, thereby reducing energy requirements, tissue tolerance, and tissue fatigue.

US Patent:

20170296813, Oct 19, 2017

Filed:

Feb 27, 2017

Appl. No.:

15/443983

Inventors:

- St. Louis MO, US
Edy Sofer - Los Angeles CA, US
Paul V. Goode - Round Rock TX, US
Bevil Hogg - Murrieta CA, US
Shai Policker - Tenafly NJ, US
Matthew Joseph Gani - Seattle WA, US
Jay Miazga - Seattle WA, US
Kaila Raby - Albuquerque NM, US

International Classification:

A61N 1/36
A61N 1/36
A61N 1/36
A61N 1/3614
A61B 5/00
A61N 1/05
A61N 1/36
A61N 1/36
A61B 5/11
A61B 5/053

Abstract:

The present specification discloses devices and methodologies for the treatment of GERD. Individuals with GERD may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow, have improved energy storage requirements, enable improved LES function while concurrently delivering additional health benefits, and enable improved LES function post stimulation termination.

US Patent:

20160030734, Feb 4, 2016

Filed:

Apr 15, 2015

Appl. No.:

14/686996

Inventors:

- St. Louis MO, US
Shai Policker - Tenafly NJ, US
Paul V. Goode - Round Rock TX, US
Bevil Hogg - Murrieta CA, US

International Classification:

A61N 1/05
A61B 1/00
A61B 7/00
A61B 8/08
A61B 5/06
A61B 6/12

Abstract:

A method of implanting electrically conductive leads in the gastrointestinal musculature for stimulation of target tissues involves an endoscopic approach through the esophagus. An endoscope is inserted into the esophagus of a patient. The mucosal surface of the anterior esophagus is punctured in the region encompassing the lower esophageal sphincter (LES). A tunnel is created through the submucosa and exits at the muscularis propria, adventitia, or serosal side of the stomach. The lead is navigated further to the anterior abdominal wall. A first end of the lead remains within the gastrointestinal musculature while a second end of the lead is positioned just outside the anterior abdominal wall. The first end of the lead comprises at least one electrode. An implantable pulse generator (IPG) is implanted and operably connected to the second end of the lead to provide electrical stimulation to target tissues.

US Patent:

20160001071, Jan 7, 2016

Filed:

Mar 23, 2015

Appl. No.:

14/665226

Inventors:

- St. Louis MO, US
Edy Sofer - Los Angeles CA, US
Paul V. Goode - Round Rock TX, US
Bevil Hogg - Murrieta CA, US
Shai Policker - Tenafly NJ, US
Matthew Joseph Gani - Seattle WA, US
Jay Miazga - Seattle WA, US
Kaila Raby - Albuquerque NM, US

International Classification:

A61N 1/36
A61N 1/05

Abstract:

The present specification discloses devices and methodologies for the treatment of GERD. Individuals with GERD may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow, have improved energy storage requirements, enable improved LES function while concurrently delivering additional health benefits, and enable improved LES function post stimulation termination.

US Patent:

20150066109, Mar 5, 2015

Filed:

Sep 3, 2014

Appl. No.:

14/475736

Inventors:

- St. Louis MO, US
Shai Policker - Tenafly NJ, US
Virender K. Sharma - Paradise Valley AZ, US
Paul V. Goode - Round Rock TX, US
Bevil Hogg - Murrieta CA, US

International Classification:

A61N 1/36

US Classification:

607 59, 607 72

Abstract:

Methods for electrically stimulating body tissues to improve function or reduce symptoms provide an electrical stimulation system having two or more electrodes that are capable of being switched independently from a hyperpolarizing (depolarizing) state to a hypopolarizing state. Multiple combinations of hyperpolarizing electrodes and hypopolarizing electrodes are created by polarity switching to determine a polarity configuration having the best performance as determined by symptom reporting and clinical diagnostic tests. Polarity switching is triggered manually or is programmed to be switched automatically. Determining the configuration providing electrical stimulation resulting in the greatest benefit allows the system to be operated with one or more electrodes in a hypopolarizing state, thereby reducing energy requirements, tissue tolerance, and tissue fatigue.